Winters, CA, United States of America

Marvin H Goodrow

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of California. Active years: 2000.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marvin H. Goodrow: Innovator in Biologically Stable Inhibitors

Introduction

Marvin H. Goodrow is a notable inventor based in Winters, California. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for soluble epoxide hydrolases. His work has implications for therapeutic applications, including the treatment of inflammation.

Latest Patents

Goodrow holds a patent for "Epoxide hydrolase complexes and methods therewith." This invention provides biologically stable inhibitors of soluble epoxide hydrolases. These inhibitors can be utilized in various applications, such as selectively inhibiting epoxide hydrolase in therapeutic contexts, affinity separations, and agricultural uses. The preferred compounds for this invention have a specific structure that includes nitrogen, oxygen, or sulfur, with various substituents that enhance their efficacy.

Career Highlights

Goodrow is affiliated with the University of California, where he continues to advance research in his field. His innovative work has led to the development of methods that can significantly impact therapeutic strategies and agricultural practices.

Collaborations

Throughout his career, Goodrow has collaborated with esteemed colleagues, including Bruce D. Hammock and James Sanborn. These partnerships have fostered advancements in research and innovation.

Conclusion

Marvin H. Goodrow's contributions to the field of biochemistry through his patent on epoxide hydrolase inhibitors highlight his role as a significant inventor. His work not only advances scientific understanding but also opens new avenues for therapeutic and agricultural applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…